MDMG.L Regulatory News (MDMG)

MD Medical Group opens new hospital in Samara

5 March 2018, Moscow - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), a leading Russian private healthcare provider, announces that it has opened a new multi-disciplinary hospital in Samara ("IDK Hospital"), the largest facility of its kind in the Volga region. Construction of the hospital began in 2Q 2016 and was completed to schedule.

Mother&Child Samara has 15,000 sq m of space, with six storeys. The hospital has 164 beds and annual capacity of up to 2,500 deliveries, up to 1,200 IVF cycles, 220,000 out-patient visits and 8,000 surgical operations. Total investment in the project amounted to 3.2 billion roubles.

The hospital in Samara will operate to MD Medical Group's customary high standards of medical care. It has out-patient facilities for both adults and children, and a separate paediatric facility providing in-patient medical care for children. Round-the clock medical care for adults will be offered by the in-patient facility in areas including urology, general surgery, traumatology, orthopaedics, gynaecology and cardiovascular surgery. In-patient and out-patient treatments in OBGYN and perinatology will enable the active development of new multi-disciplinary medical areas for the Samara Region, such as foetal medicine and organ-sparing surgery using endovascular technologies.

Mother&Child Samara has eight high-tech operating theatres including one integrated facility that allows remote consultations with doctors at other MDMG facilities, meaning that surgical operations can be carried out using telemedicine technology.

The hospital's diagnostics centre will offer an extensive range of services including CT, MRI, mammography, X-ray and ultrasound diagnostics, endovascular surgery, an endoscopy department and a diagnostics laboratory capable of carrying out more than 1,000 types of tests including genetic testing (gene mapping, Karyotype testing, and diagnosis of hereditary diseases).

MD Medical Group has assembled an excellent team of doctors for the Samara hospital including some of the Group's leading specialists from Moscow, Samara and other cities. The Company also plans to work with Samara Medical University, which enjoys a strong reputation, and to benefit from synergies with other hospitals and facilities in the Mother&Child network across Russia's regions.

Mark Kurtser, CEO of MD Medical Group, said:

"The opening of Mother&Child Samara demonstrates our ability to execute strategically important projects on time and on budget. The new hospital represents a substantial strengthening of the Company's position in an important and growing market in the south-east of the European part of Russia. As well as Samara itself, the hospital will offer medical services to surrounding areas in the Volga region, thanks to the hospital's easily accessible location just outside Samara with advanced transportation infrastructure that has been put in place for the World Cup games in the city.

"MD Medical Group has a solid track record in the Samara Region, with several clinics successfully operating in the city already for a number of years and the IDK Medical Company that we acquired in 2013 enjoying a strong reputation as one of the leading private healthcare providers. The creation of a regional base and establishment of local brand awareness and subsequent construction of a major hi-tech medical centre with a strong team of doctors is in line with our long-term development strategy which includes creating a chain of multi-disciplinary hospitals in Russia's regions.

"We are proud that the new hospital in Samara will make high-quality medical care accessible to hundreds of thousands of people in the Volga region."

Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) and MD Medical Group Board member added:

"The team at MD Medical Group not only exhibits the highest levels of professionalism in providing medical care but they are also successfully expanding the network. Investors welcome the development and opening of ultra-modern hospitals which have a positive impact not only on the communities and economies of the regions where they are located, but also on the financial performance of the company. We are pleased that RDIF and its co-investors are contributing to projects which are both profitable and worthwhile.

"The opening of the hospital in Samara clearly demonstrates the effectiveness of MDMG's regional growth strategy and the quality of its management team. It also underpins the confidence of investors and partners in the Company's continued dynamic growth, scientific and technological development, as well as the strengthening of its leading position in the market."

For further information please contact:

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 35 modern healthcare facilities, including 5 hospitals and 30 outpatient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, and Voronezh.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

Forward-Looking Statements:

This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.